Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial-Reference-Cited by-同舟云学术

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

Published:2009-11 Issue:11 Volume:10 Page:1037-1044
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Chang Eric L,Wefel Jeffrey S,Hess Kenneth R,Allen Pamela K,Lang Frederick F,Kornguth David G,Arbuckle Rebecca B,Swint J Michael,Shiu Almon S,Maor Moshe H,Meyers Christina A

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Management of brain metastases;Posner;Revue Neurologique (Paris),1992

2. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial;Andrews;Lancet,2004

3. A randomized trial of surgery in the treatment of single metastases to the brain;Patchell;N Engl J Med,1990

4. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery;Vecht;Ann Neurol,1993

5. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone;Chang;Neurosurgery,2007

Cited by 2076 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma Brain Metastasis;Hematology/Oncology Clinics of North America;2024-10

2. Brain Metastases as Inaugural Sign of Non-Small Cell Lung Carcinoma: Case Series and Review of Literature;Cancers;2024-09-08

3. Brain Metastases in Differentiated Thyroid Cancer: Clinical Presentation, Diagnosis, and Management;Thyroid®;2024-09-04

4. The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases;CLIN LUNG CANCER;2024

5. The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases;Clinical Lung Cancer;2024-09